New drug 611 aims to cut COPD attacks in chinese patients
NCT ID NCT07039669
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This Phase 3 trial tests whether the experimental drug 611 can reduce moderate to severe COPD flare-ups in Chinese adults aged 40-85 with moderate to severe COPD. About 594 participants will receive either 611 or a placebo injection every two weeks. The study measures how often flare-ups occur and changes in lung function over 24 weeks.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- 611 (an experimental drug given as a subcutaneous injection)
- What this could lead to
- If successful, 611 could become a new treatment option to reduce the number of COPD flare-ups and help people breathe better.
- What could go wrong
- This is a Phase 3 trial, but it's still experimental. It may not work better than placebo, and side effects are possible. Results may only apply to Chinese adults.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PULMONARY DISEASE, CHRONIC OBSTRUCTIVE (COPD) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
China-Japan Friendship Hospital
NOT_YET_RECRUITINGBeijing, Beijing Municipality, 100029, China
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Jiangsu Province Hospital
RECRUITINGNanjing, Jiangsu, 212028, China
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Shenzhen People's Hospital
RECRUITINGShenzhen, Guangdong, 518020, China
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
ZheJiang Provincial People's Hospital
NOT_YET_RECRUITINGHangzhou, Zhejiang, 310014, China
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Smart sensors aim to predict dangerous COPD attacks before they happen
- Smart breathing machines at home could cut hospital visits for COPD patients
- Can 'Box Breathing' help COPD patients catch their breath?
- New oxygen gadget boosts exercise in COPD patients
- Real-World COPD study tracks benefits of switching to triple inhaler
- Swedish Mega-Study scans 1,400 for clues to heart, lung, and liver disease